Connecting METTL3 and intratumoural CD33+ MDSCs in predicting clinical outcome in cervical cancer
2020 · Journal of Translational Medicine · 89 citations
https://doi.org/10.1186/s12967-020-02553-z
S
Shuqin Dai
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
67
Papers
798
Citations
15
h-index
19
i10-index
Shuqin Dai is an academic researcher from Jiangnan University. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Lung Cancer Diagnosis and Treatment & RNA modifications and cancer. The author has an h-index of 15, co-authored 57 publications.
ORCID: 0000-0003-2586-6989Papers by this author
worksA novel score based on serum apolipoprotein A-1 and C-reactive protein is a prognostic biomarker in hepatocellular carcinoma patients
2018 · BMC Cancer · 31 citations
https://doi.org/10.1186/s12885-018-5028-8
High serum HER2 extracellular domain levels: correlation with a worse disease-free survival and overall survival in primary operable breast cancer patients
2011 · Journal of Cancer Research and Clinical Oncology · 21 citations
https://doi.org/10.1007/s00432-011-1095-9
Chemokine CCL27 is a novel plasma biomarker for identification the nasopharyngeal carcinoma patients from the Epstein-Barr virus capsid antigen-specific IgA seropositive population
2018 · BMC Cancer · 13 citations
https://doi.org/10.1186/s12885-017-3718-2
Cytokeratin19-2g2, a Novel Fragment of Cytokeratin19 in Serum, Indicating a More Invasive Behavior and Worse Prognosis in Breast Cancer Patients
2013 · PLoS ONE · 9 citations
https://doi.org/10.1371/journal.pone.0057092
Clinical significance of serum estradiol monitoring in women receiving adjuvant aromatase inhibitor for hormone receptor-positive early breast cancer
2024 · The Breast · 6 citations
https://doi.org/10.1016/j.breast.2024.103818
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat